These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 13677477)

  • 21. Is restoration of intracellular trafficking clinically feasible in the long QT syndrome?: The example of HERG mutations.
    Kaufman ES; Ficker E
    J Cardiovasc Electrophysiol; 2003 Mar; 14(3):320-2. PubMed ID: 12716119
    [No Abstract]   [Full Text] [Related]  

  • 22. Spironolactone and its main metabolite, canrenoic acid, block human ether-a-go-go-related gene channels.
    Caballero R; Moreno I; González T; Arias C; Valenzuela C; Delpón E; Tamargo J
    Circulation; 2003 Feb; 107(6):889-95. PubMed ID: 12591761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Of oocytes and runny noses.
    Rosen MR
    Circulation; 1996 Aug; 94(4):607-9. PubMed ID: 8772677
    [No Abstract]   [Full Text] [Related]  

  • 24. HERG K+ channels and beta1 integrins interact through the assembly of a macromolecular complex.
    Cherubini A; Pillozzi S; Hofmann G; Crociani O; Guasti L; Lastraioli E; Polvani S; Masi A; Becchetti A; Wanke E; Olivotto M; Arcangeli A
    Ann N Y Acad Sci; 2002 Nov; 973():559-61. PubMed ID: 12485929
    [No Abstract]   [Full Text] [Related]  

  • 25. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG.
    Rampe D; Roy ML; Dennis A; Brown AM
    FEBS Lett; 1997 Nov; 417(1):28-32. PubMed ID: 9395068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ion channels. A new wave for heart rhythms.
    Attali B
    Nature; 1996 Nov; 384(6604):24-5. PubMed ID: 8900269
    [No Abstract]   [Full Text] [Related]  

  • 27. LQT2 : amplitude reduction and loss of selectivity in the tail that wags the HERG channel.
    Robertson GA
    Circ Res; 2000 Mar; 86(5):492-3. PubMed ID: 10720408
    [No Abstract]   [Full Text] [Related]  

  • 28. The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG.
    Rampe D; Murawsky MK; Grau J; Lewis EW
    J Pharmacol Exp Ther; 1998 Aug; 286(2):788-93. PubMed ID: 9694935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antipsychotics, HERG and sudden death.
    Witchel HJ; Hancox JC; Nutt DJ; Wilson S
    Br J Psychiatry; 2003 Feb; 182():171-2. PubMed ID: 12562748
    [No Abstract]   [Full Text] [Related]  

  • 30. Congenital and acquired long QT syndrome.
    Camm AJ; Janse MJ; Roden DM; Rosen MR; Cinca J; Cobbe SM
    Eur Heart J; 2000 Aug; 21(15):1232-7. PubMed ID: 10924312
    [No Abstract]   [Full Text] [Related]  

  • 31. Cocaine blocks HERG, but not KvLQT1+minK, potassium channels.
    Zhang S; Rajamani S; Chen Y; Gong Q; Rong Y; Zhou Z; Ruoho A; January CT
    Mol Pharmacol; 2001 May; 59(5):1069-76. PubMed ID: 11306689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug binding to HERG channels: evidence for a 'non-aromatic' binding site for fluvoxamine.
    Mitcheson JS
    Br J Pharmacol; 2003 Jul; 139(5):883-4. PubMed ID: 12839860
    [No Abstract]   [Full Text] [Related]  

  • 33. Class III antiarrhythmic drugs block HERG, a human cardiac delayed rectifier K+ channel. Open-channel block by methanesulfonanilides.
    Spector PS; Curran ME; Keating MT; Sanguinetti MC
    Circ Res; 1996 Mar; 78(3):499-503. PubMed ID: 8593709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel extracellular calcium sensing mechanism in voltage-gated potassium ion channels.
    Johnson JP; Balser JR; Bennett PB
    J Neurosci; 2001 Jun; 21(12):4143-53. PubMed ID: 11404399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular diagnosis and treatment of cardiovascular diseases.
    Duff HJ
    Can J Cardiol; 2000 Mar; 16(3):304-6. PubMed ID: 10744791
    [No Abstract]   [Full Text] [Related]  

  • 36. A virtual screening method for prediction of the HERG potassium channel liability of compound libraries.
    Roche O; Trube G; Zuegge J; Pflimlin P; Alanine A; Schneider G
    Chembiochem; 2002 May; 3(5):455-9. PubMed ID: 12007180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockade of human cardiac potassium channel human ether-a-go-go-related gene (HERG) by macrolide antibiotics.
    Volberg WA; Koci BJ; Su W; Lin J; Zhou J
    J Pharmacol Exp Ther; 2002 Jul; 302(1):320-7. PubMed ID: 12065733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652.
    Milnes JT; Crociani O; Arcangeli A; Hancox JC; Witchel HJ
    Br J Pharmacol; 2003 Jul; 139(5):887-98. PubMed ID: 12839862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interactions of the antimalarial drug mefloquine with the human cardiac potassium channels KvLQT1/minK and HERG.
    Kang J; Chen XL; Wang L; Rampe D
    J Pharmacol Exp Ther; 2001 Oct; 299(1):290-6. PubMed ID: 11561091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A plethora of mechanisms in the HERG-related long QT syndrome. Genetics meets electrophysiology.
    Roden DM; Balser JR
    Cardiovasc Res; 1999 Nov; 44(2):242-6. PubMed ID: 10690299
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.